Proliferation of an essential fatty acid deficient cell line from carp (EPC-EFAD; epithelioma papillosum carpessential fatty acid deficient) is stimulated by supplementing the cells with C 20 , but not C 18 polyunsaturated fatty acids (PUFA). It is hypothesized that the differential ability of the PUFA to stimulate proliferation of the EPC-EFAD cells may be related to the extent of the cells' ability to desaturate and elongate C 18 PUFA. In the present study, the metabolism of 14 C-labeled C 18 and C 20 PUFA was investigated in EPC-EFAD cells in comparison with normal EPC cells. The incorporation of all the PUFA was significantly greater in EPC-EFAD cells but the rank order, 20:5n-3 > 18:3n-3 = 18:2n-6 >20:4n-6 was the same in both cell lines. The proportion of radioactivity from all labeled PUFA recovered in phosphatidylethanolamine and total polar lipids was significantly lower in EPC-EFAD cells compared to EPC cells, whereas the proportion of radioactivity recovered in all the other phospholipid classes and total neutral lipid was greater in EPC-EFAD cells. Both cell lines desaturated[1-14 C]18:3n-3 and [1-14 C]20:5n-3 to a greater extent than the corresponding (n-6) substrates but the desaturation of all the 14 C-labeled PUFA was significantly greater in EPC-EFAD cells compared to EPC cells. The results showed that, although essential fatty acid deficiency had several significant effects on PUFA metabolism in EPC cells, the fatty acid desaturation/elongation pathway was not impaired in EPC-EFAD cells and so they can desaturate 18:3n-3 to
Introduction
Cultured cells have been an important in vitro tool in the study of lipid and fatty acid metabolism in mammals (Bailey and Dunbar 1973; Ferguson et al. 1975; Maeda et al. 1978; Spector et al. 1981; Masuzawa et al. 1986; Isseroff et al. 1987) . Most cells in culture, including fish cells, generally require the medium to be supplemented with serum which, along with various hormones and growth factors, also provides lipid and fatty acids to the cells (Sato 1975; Bailey and Dunbar 1973) . Despite this, mammalian cell lines have been developed that can grow in either serumfree medium or delipidated sera which has enabled the effects of essential fatty acid deficiency to be investigated in cell lines in vitro (Laposata et al. 1982; Marcelo et al. 1992; Lerner et al. 1995) . The development of a fish cell line that could grow in the absence of serum, and hence exogenously added fatty acids, had added importance as the commercial mammalian sera used in cell culture, including fish cell culture, distort the fatty acid composition of the fish cells in that they display lower percentages of n-3 PUFA and are enriched in n-6 PUFA in comparison with fish tissues (Henderson and Tocher 1987; .
Consequently, we developed a fish cell line, EPC-EFAD, derived from the carp (Cyprinus carpio) epithelial papilloma line, EPC, that can survive and proliferate in essential fatty acid-deficient (EFAD) medium . Proliferation of the EPC-EFAD cells was stimulated by supplementing the cells with arachidonic (20:4n-6), eicosapentaenoic (20:5n-3) and docosahexaenoic (22:6n-3) acids but not by 18:2n-6 or 18:3n-3 (Tocher et al. 1996) . It was hypothesized that the differential ability of the PUFA to stimulate proliferation of the EPC-EFAD cells may be related to the extent of the cells' ability to desaturate and elongate C 18 PUFA. In the present study, the metabolism of 14 C-labeled C 18 and C 20 PUFA was investigated in EPC-EFAD cells in comparison with EPC cells that were not essential fatty acid deficient. In particular, the effects of essential fatty acid deficiency on fatty acyl desaturation and elongation activities were investigated.
Materials and methods

Cells and media
The carp (Cyprinus carpio) epithelioma papillosum cell (EPC) line, which retains epithelial morphology, was routinely maintained in Leibovitz L-15 medium and supplemented with 2 mM glutamine, antibiotics (50 I.U ml −1 penicillin and 50 mg ml −1 streptomycin) and 10% fetal bovine serum (FBS). EPC-EFAD cells were derived from EPC cells by subculture in Leibovitz L-15 medium with exactly the same supplements except that the FBS was delipidated prior to use, essentially as described by Capriotti and Laposata (1986) . The delipidated FBS contained approximately 10 µg of fatty acids per g of serum (0.001% by weight) with less than 2 µg/g of C 18 PUFA, predominantly 18:2(n-6) (Tocher et al. , 1996 . The EPC-EFAD cells used in the experiments had been maintained continuously in delipidated medium for 3 years and were at passage number 52-55.
Incubation conditions
The EPC and EPC-EFAD cells were cultured at 22 • C in sealed plastic tissue culture flasks. EPC cells were cultured in standard tissue culture flasks (Corning Costar, High Wycombe, U.K.), whereas the EPC-EFAD line was cultured in surface-modified 'Primaria' flasks (Falcon, Becton Dickinson UK Ltd., Oxford). Both EPC and EPC-EFAD lines were cultured in 75 cm 2 (routine culture for provision of experimental material) or 25 cm 2 ( 14 C-metabolism) flasks and were subcultured within 24 h of reaching confluence at seeding densities of 1 × 10 5 cells cm −2 in EPC and 2 × 10 5 cells cm −2 in EPC-EFAD, to account for the slower proliferation rate of the EPC-EFAD cells in delipidated FBS (Tocher et al. ,1996 . For each experimental sample, 3 × 25 cm 2 flasks were seeded and this experiment was repeated three times to obtain the replicates.
Incubation of cultures with 14 C-labeled polyunsaturated fatty acids
The medium was aspirated, cultures washed with Dulbecco's phosphate-buffered saline (PBS) and fresh Leibovitz L-15 medium, as above but without supplemental serum or delipidated serum, was added. The 14 C-labeled PUFAs ([1-14 C] 18:2n-6, [1-14 C] 18:3n-3, [1-14 C] 20:4n-6 and [1-14 C] 20:5n-3; 0.2 µCi per flask; concentration, 0.8 µM) were added to the cell cultures bound to fatty acid-free bovine serum albumin (BSA) in phosphate buffered saline (Ghioni et al. 1997) and incubation continued for 6 days at 22 • C.
Lipid extraction and incorporation of radioactivity into total lipid
The medium was aspirated and cultures washed twice with 20 ml of ice-cold Hanks' balanced salt solution without calcium and magnesium (HBSS). Cells were harvested by trypsinization with 0.05% trypsin/0.5 mM ethylenediamine tetraacetic acid (EDTA), washed with 5 ml ice-cold HBSS and a sample taken for protein determination. The cells were washed with 5 ml HBSS containing 1% fatty acidfree BSA and total lipid extracted from the cell pellets with 5 ml ice-cold chloroform/methanol (2:1, v/v) containing 0.01% butylated hydroxytoluene (BHT) as antioxidant, according to Folch et al. (1957) as described in detail previously . Lipid content was determined gravimetrically after 1 h vacuum desiccation and the lipid resuspended in chloroform/methanol (2:1, v/v) containing BHT, at a lipid concentration of 10 mg ml −1 , and samples stored at −20 • C before analyses. The radioactive content of total lipid was determined in 3 aliquots of 5 µl in mini-vials containing 2.5 ml scintillation fluid (Ecoscint A; National Diagnostics, Atlanta, USA) using a TRI-CARB 2000CA liquid scintillation spectrophotometer (United Technologies Packard). Results were corrected for counting efficiency and quenching using an appropriate calibration curve. All solvents contained 0.01% BHT as antioxidant.
Incorporation of radioactivity into glycerophospholipid classes
Samples of total lipid (100 µg) were applied as 1 cm streaks to high-performance thin-layer chromatography (HPTLC) plates, and the polar lipid classes separated using methyl acetate/propan-2-ol/chloroform/methanol/0.25% aqueous KCl (25: 25: 25: 10: 9, by vol.) as developing solvent (Vitiello and Zanetta 1978) . After desiccation, the lipid classes were visualized by brief exposure to iodine vapor and areas corresponding to phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidic acid/cardiolipin (PA/CL) and total neutral lipid (TN) were scraped into scintillation vials containing 2.5 ml scintillation fluid and radioactivity determined as above.
Incorporation of radioactivity into polyunsaturated fatty acids
Total lipid extracts were transmethylated overnight at 50 • C in methanolic sulfuric acid (Christie 1982) . Fatty acid methyl esters (FAME) were extracted, after addition of 2 ml 2% KHCO 3 , with hexane/diethyl ether (1:1, v/v) containing 0.01% BHT. Solvent was evaporated and samples were resuspended in 100 µl hexane containing BHT. Samples were applied as 1 cm streaks on HPTLC plates and then developed with hexane/diethyl ether/acetic acid (90:10:1, by vol.). FAME were detected under UV light by comparison with known standards after spraying with 2 , 7 -dichlorofluorescein. FAME were eluted from the silica with hexane/diethyl ether (1:1, v/v), solvent evaporated and the purified samples resuspended in hexane/BHT. Thin layer chromatography (TLC) plates were impregnated by spraying with 2 g silver nitrate in 20 ml acetonitrile and activated at 110 • C for 30 min. FAME were applied as 2.5 cm streaks and plates developed with toluene/acetonitrile (95:5, v/v) to separate PUFA (Wilson and Sargent 1992) . Autoradiography was performed using Kodak MR2 film for 7 days at room temperature. Silica corresponding to different FAME was scraped into scintillation vials containing 2.5 ml scintillation fluid and radioactivity determined as described above.
Lipid class and fatty acid composition
Separation and quantification of lipid classes was performed by single-dimension double-development HPTLC followed by scanning densitometry as described previously (Henderson and Tocher 1992) . Fatty acid methyl esters (FAME) were prepared by acid-catalyzed transmethylation, extracted and purified by HPTLC as described previously (Tocher and Harvie 1988) . Analysis of FAME was performed by GC in a Fisons GC8000 gas chromatograph (Crawley, UK) equipped with a fused-silica capillary column (30 m × 0.32 mm i.d., CP Wax 52 CB, Chrompack, UK) using hydrogen as carrier gas. Temperature programming was from 50 to 150 • C at 35 • C/min and to 225 • C at 2.5 • C/min. Individual FAME were identified by comparison with known standards and published data (Ackman 1980; Bell et al. 1983 ).
Protein determination
The protein content of the cells was determined according to the method of Lowry et al. (1951) after incubation with 0.25 ml of 0.25% (wt/vol) sodium dodecyl sulfate/1 M NaOH for 45 min at 60 • C.
Materials
[1-14 C] PUFA (all ∼50 mCi.mmol −1 and 99% pure) were obtained from NEN Life Science Products (Hounslow, U.K.). Leibovitz L-15 medium, HBSS, PBS, glutamine, penicillin, streptomycin, FBS, trypsin/EDTA , fatty acid-free BSA and BHT were obtained from Sigma Chemical Co. Ltd. (Poole, UK). TLC plates (20 cm × 20 cm × 0.25 mm) and HPTLC plates (10 cm × 10 cm × 0.15 mm), pre-coated with silica gel 60 were obtained from Merck, (Darmstadt, Germany). All solvents were of HPLC grade and were obtained from Rathburn Chemicals (Walkerburn, Peebleshire, Scotland).
Statistical analysis
All results are means ±SD of three experiments. Where indicated, data were subjected to two-way analysis of variance (ANOVA) and where appropriate the significance of differences were determined by Tukey's test. Percentage data were subjected to arc-sin transformation prior to ANOVA. When appropriate, the significance of differences between some means were determined by the Student t-test. Differences are reported as significant when p < 0.05 (Zar 1984) .
Results
The lipid content of the essential fatty acid deficient cells (EPC-EFAD) was significantly lower than the normal cells (EPC) ( Table 1) . Due to this, the absolute amounts of all lipid classes were lower in EPC-EFAD cells (data not shown). In relative terms, both cell lines showed lipid class compositions that were predominantly polar lipids with cholesterol as the only major neutral lipid with the EPC-EFAD cells having a significantly higher percentage of polar lipids and lower cholesterol compared to EPC cells (Table 1 ). The proportions of the main phospholipids, phosphatidylcholine (PC) and phosphatidylethanolamine (PE), in both cell lines were unchanged although the EPC-EFAD cells had significantly increased percentages of many of the more minor polar lipids. Due to the decreased amount of lipid, the absolute amounts of all the fatty acid groups were significantly reduced in EPC-EFAD cells (Table 2 ). In particular, the lipid of EPC-EFAD cells contained very little (n-3) or (n-6) PUFA, with the totals and all individual PUFA being very significantly lower than in EPC cells ( Table 2 ). The relative proportions of total saturated fatty acids, in particular the predominant 16:0 and 18:0 acids, were also significantly lower in EPC-EFAD cells although shorter chain 12:0 and 14:0 were significantly higher. In contrast, the relative amount of total monounsaturated fatty acids was significantly increased in EPC-EFAD cells although the proportion of 18:1n-9 was reduced while the proportions of (n-9) PUFA were increased (Table 2) . Two-way analysis of variance (ANOVA) showed that the incorporation of 14 C-labeled PUFA was significantly greater in EPC-EFAD cells irrespective of the PUFA added or the way the results were expressed (Table 3 ). Irrespective of cell line, i.e., EPC or EPC-EFAD, the incorporation of [1-14 C]20:5n-3 was significantly greater than any other fatty acid and the incorporation of [1-14 C]20:4n-6 was lower than the other PUFA with the rank order for the incorporation being 20:5n-3 > 18:3n-3 = 18:2n-6 > 20:4n-6.
The distribution of radioactivity from the added 14 C-labeled PUFA in individual lipid classes in EPC and EPC-EFAD cells is shown in Table 4 . Two-way ANOVA showed that this distribution was significantly affected by the cell line and was dependent upon the specific 14 C-fatty acid (Table 5) . Qualitatively, the distribution of the PUFA was similar in both cell lines, with all PUFAs preferentially incorporated into polar lipids. The incorporation of the 14 C-labeled C 18 PUFAs was greater into PC, phosphatidic acid/cardiolipin (PA/CL) and total neutral lipids, compared to the 14 C-labeled C 20 PUFAs (Tables 4  and 5 ). [1-14 C]20:5n-3 was preferentially incorporated into PE and [1-14 C]20:4n-6 was preferentially incor- 16:1 (n-9) 2.7 ± 0.1 1.8 ± 0.0 * 0.30 ± 0.01 0.12 ± 0.00 * 16:1 (n-7)
2.2 ± 0.1 5.7 ± 0.1 * 0.25 ± 0.01 0.41 ± 0.01 * 18:1 (n-9) 34.9 ± 0.1 31.9 ± 0.1 * 3.91 ± 0.01 2.30 ± 0.01 * 18:1 (n-7)
4.7 ± 0.2 10.8 ± 0.1 * 0.53 ± 0.02 0.78 ± 0.01 * 18:1 (n-5) n.d. .2 ± 1.0 34.1 ± 0.4 1 9 .7 ± 0.1 28.1 ± 1.4 PE 45.1 ± 0.9 39.1 ± 0.6 6 2 .9 ± 0.4 50.7 ± 0.9 PS 7.5 ± 0.2 9.8 ± 0.2 9 .2 ± 0.4 10.9 ± 0.2 PI 2.5 ± 0.0 3.0 ± 0.2 3 .7 ± 0.4 4.3 ± 0.2 PA/CL 9.1 ± 0.2 11.6 ± 0.2 3 .2 ± 0.5 4.3 ± 0.1 TP 97.4 ± 0.1 97.6 ± 0.2 9 8 .7 ± 0.1 98.3 ± 0.2 TN 2.6 ± 0.1 2.4 ± 0.2 1 .3 ± 0.1 1.7 ± 0.2
Results are expressed as percentages of total radioactivity recovered and are means ±SD (n = 3). CL, cardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; TN, total neutral lipids; TP, total polar lipids. Table 5 . Results of two-way analysis of variance (ANOVA) for the data in Table 4 Lipid porated into phosphatidylinositol (PI). Quantitatively though, there were significant differences between the cell lines. The proportion of radioactivity from all labeled PUFA recovered in PE and total polar lipids was significantly lower in EPC-EFAD cells compared to EPC cells, whereas the proportion of radioactivity recovered in all the other phospholipid classes and total neutral lipid was increased in EPC-EFAD cells (Tables  4 and 5 ). EPC cells metabolized the n-3 PUFA, [1-14 C]18:3n-3 and [1-14 C]20:5n-3, to a greater extent than the corresponding (n-6) substrates (Table 6 ). Very little tetraene and pentaene products were formed from [1-14 C]18:2n-6 and [1-14 C]20:4n-6, respectively, in EPC cells. In contrast, [1-14 C]18:3n-3 was metabolized to 20:5n-3 and 22:6n-3, and [1-14 C]20:5n-3 was metabolized to 22:6n-3 (Table 6 ). Desaturation of all the 14 C-labeled PUFA was significantly greater in EPC-EFAD cells compared to EPC cells (Table 6) . With [1-14 C]18:2n-6, the proportion of radioactivity recovered in the main desaturation product, 20:3n-6, was significantly increased in EPC-EFAD cells, as was 20:4n-6 and 22:4n-6, whereas the proportion of radioactivity recovered in 18:2n-6 was significantly reduced. With [1-14 C]18:3n-3, the proportions of radioactivity recovered in 20:5n-3, 22:5n-3 and 22:6n-3 were all significantly greater and the proportions recovered in almost all the trienes and tetraenes were reduced in EPC-EFAD cells (Table 6 ). The recovery of radioactivity in 22:6n-3 was significantly greater in EPC-EFAD cells incubated with [1-14 C]20:5n-3 compared to EPC cells, whereas the proportions of radioactivity recovered in 20:5n-3 and the elongation products, 22:5n-3 and 22:4n-3, were significantly lower. There was significantly more radioactivity recovered in 22:5n-6 in EPC-EFAD cells incubated with [1-14 C]20:4n-6 compared to EPC cells.
The apparent activity at each step in the desaturation/elongation pathway was estimated by adding the percentages of radioactivity recovered in all fatty acid metabolites for each step, irrespective of subsequent metabolism by another activity (Table 7) . This showed that the metabolism of [1-14 C]18:2n-6 in EPC-EFAD cells was increased at the level of 6 desaturase whereas the metabolism [1-14 C]18:3n-3 did not appear to be greatly increased at this level. However, the desaturation of [1-14 C]18:3n-3 appeared to be increased in EPC-EFAD cells at 5 desaturase and subsequent steps although preceding activities may still be influencial. The metabolism of [1-14 C]20:5n-3 appeared to be primarily increased in EPC-EFAD cells at a step after the C 20−22 elongase.
Discussion
The main effects on lipid composition of three years continuous culture in delipidated serum were decreased lipid content and decreased levels of n-3 and n-6 PUFA in EPC-EFAD cells. The very low levels of n-3 and n-6 PUFA in EPC-EFAD cells were accompanied by decreased proportions of cholesterol, saturates (other than short chain 12:0 and 14:0) and increased proportions of n-9 PUFA and monoenes which would compensate for the effects on membrane unsaturation and fluidity. These compositional effects in EPC-EFAD cells were accompanied by increased incorporation of the labeled PUFA. Net 'incorporation' is actually based on the recovery of radioactivity and represents uptake minus the amount oxidized or lost via other metabolic pathways. However, all fatty acids 0.5 ± 0.1 2.6 ± 0.1 * 96.3 ± 0.9 94.9 ± 0.8 22:4n-6 n.d. 2.5 ± 0.2 * 1.5 ± 0.4 1.9 ± 0.3 24:4n-6 n.d. 20:3n-3 17.6 ± 0.8
8.1 ± 0.3 13.7 ± 0.4 * 29.8 ± 3.5 39.3 ± 1.3 * 22:5n-3 11.0 ± 0.6 15.0 ± 0.1 * 40.7 ± 0.1 32.0 ± 1.2 * 24:5n-3 n.d. n.d. 17.8 ± 0.4 6.7 ± 0.2 * 22:6n-3 2.7 ± 0.2 11.9 ± 0.2 * 11.7 ± 4.0 22.1 ± 0.9 * Results are expressed as percentages of total radioactivity recovered in total lipid and are means ±SD (n = 3). Differences between values for EPC and EPC-EFAD cells for each [1-14 C] PUFA were significantly different where indicated ( * ) as determined by the Student t-test (p < 0.05). n.d., not detected. Results are presented as percentages of total radioactivity recovered. All fatty acid metabolite for a given step in the pathway were summed, irrespective of subsequent metabolism by another activity (e.g. for [1-14 C]18:2n-6, ' 6 products' represents the sum of radioactivity recovered as 18:3n-6, 20:3n-6, 22:3n-6, 20:4n-6, 22:4n-6 and 22:5n-6). n.d., not detected.
were used at the same concentration and so the amount taken up and oxidized will only be dependent on the fatty acid and the cell type. The differences in incorporation between the fatty acids were similar in the two cell lines showing that essential fatty acid deficiency had affected these processes similarly for all fatty acids. However, the primary aims of the present study were to precisely determine the ability of EPC cells to desaturate and elongate PUFA, particularly C 18 PUFA, and to investigate the effects of essential fatty acid deficiency on that pathway. The results of the present study demonstrated that the EPC cell line is capable of desaturating 18:3n-3 to 20:5n-3 and, to a lesser extent, 22:6n-3. Similarly, 18:2n-6 was converted to 20:4n-6 in EPC cells although 20:3n-6 was the main product. EPC-EFAD cells also exhibited the full desaturation/elongation pathway and indeed essential fatty acid deficiency significantly increased the desaturation of 18:3n-3 to 20:5n-3 and 22:6n-3, and 18:2n-6 to 20:4n-6.
The aims of the present study arose from previous studies that had shown that C 18 PUFA (18:3n-3 and 18:2n-6) did not stimulate proliferation of EPC-EFAD cells, whereas C 20 and C 22 were effective in increasing the proliferation rate of the essential fatty acid deficient cells (Tocher et al. 1996) . The fatty acid compositional data in the previous study had suggested that the EPC-EFAD cells had only limited 5 desaturase activity based on the fact that the level of 20:4n-6 in total lipid was not significantly increased after supplementation with 18:2n-6 and that the levels of 20:5n-3 (and 22:6n-3) were not increased after supplementing with 18:3n-3 (Tocher et al. 1996) . This was unexpected as, firstly, the EFA requirements of common carp are known to be met by C 18 PUFA alone, specifically about 1% each of 18:3n-3 and 18:2n-6 (Takeuchi and Watanabe 1977) . Secondly, a deficiency in the desaturase pathway had been widely perceived to be a trait of marine fish, especially carnivorous marine fish, and so it was unexpected to have an apparent deficiency in a cell line from a largely herbivorous freshwater species Tocher et al. 1998 ). However, it was known that many cultured cell lines appear to lack, or display low levels of activity, of certain enzymes of the fatty acid desaturation/elongation pathway ). Therefore, it was possible that EPC (and EPC-EFAD) cells no longer reflected the situation in carp and had lost an enzyme activity in the fatty acid desaturation/elongation pathway. The present study has demonstrated that this is not the case and that both the EPC and EPC-EFAD cell lines have the fatty acid desaturation/elongation profile expected of cells from a freshwater fish.
In the previous study, levels of 20:4n-6 and 20:5n-3 were increased by supplementing EPC-EFAD cells with 20:4n-6 and 20:5n-3, and 20:5n-3 was also very significantly increased by supplementation with 22:6n-3 (Tocher et al. 1996) . In contrast, 20:5n-3 and 20:4n-6 were not increased by supplementing EPC-EFAD cells with 50 µM unlabeled 18:3n-3 and 18:2n-6, respectively. This had suggested that eicosanoids may be implicated in the mechanism of stimulation of proliferation (Tocher et al. 1996) . The data from the present study is not inconsistent with the data from the previous study and can support the view that eicosanoids are involved. In the previous study, 20:3n-6 was significantly increased by supplementing with 18:2n-6 and this is supported by the data in the present study which shows that 20:3n-6 was the main product of [1-14 C]18:2n-6 desaturation and that the residual 18:2n-6 (∼1.5 µg g −1 ) in delipidated serum is converted to 20:3n-6. A relative accumulation of radioactivity in 20:3n-6 in EFA deficient human Hep G2 cells incubated with tracer amounts of 14 C-labeled 18:2n-6 was reported previously (Melin and Nilsson 1997) . Similarly, supplementing EPC-EFAD cells with 18:3n-3 in the previous study significantly increased the levels of both 20:3n-3 and 20:4n-3, and 20:4n-3 was a major product of [1-14 C]18:3n-3 desaturation in the present study. It is well known that 20:3n-6 can modulate the production and efficacy of 20:4n-6-derived eicosanoids via competitive inhibition and as the precursor of eicosanoids with attenuated biological properties (Horrobin 1992; Bell et al. 1994) . Similarly, 20:4n-3 can be converted to eicosanoids with attenuated properties in mammalian tissues and inhibit 20:4n-6 metabolism in human leukocytes (Oliw et al. 1986a, b; Samel et al. 1987; Careaga and Sprecher 1987; Guichardant et al. 1993) . Eicosanoids, particularly prostaglandins, are known to be highly involved in the regulation of cellular proliferation (Wickremasinghe 1988; Skouteris et al. 1988 ) including fish cells (Secombes et al. 1994; Rowley et al. 1995) .
Therefore, the data in the present study are consistent with 18:2n-6 failing to stimulate proliferation of EPC-EFAD cells due to the accumulation of 20:3n-6 rather than 20:4n-6. However, although the present data can explain the accumulation of both 20:3n-3 and 20:4n-3 in EPC-EFAD cells supplemented with 18:3n-3 it is unclear why 18:3n-3 did not appear to be significantly converted to 20:5n-3 and 22:6n-3 in the earlier study. This discrepancy between the two studies may be related to fatty acid concentration as a relatively high concentration of 50 µM was used previously whereas the labeled fatty acids in the present study were used at tracer concentrations of less than 1 µM. Differences in metabolism due to fatty acid concentration have been noted previously (Melin and Nilsson 1997) .
Essential fatty acid deficiency had other effects on PUFA metabolism in EPC cells. In EPC-EFAD cells, the distribution of the PUFA in phospholipid classes was altered with the main effect, observed with all the PUFA, being decreased amounts incorporated in PE and increased in PC. This may reflect lowered specificity between phospholipid classes in EPC-EFAD cells, in which all the phospholipids are essentially lacking their normal complement of PUFA. Therefore, PC, the predominant phospholipid class, accumulates relatively more PUFA in EPC-EFAD cells than in EPC cells. However, alterations in the relative incorporation of PUFA into PC and PE have been observed before in fish cell lines in response to other factors such as culture temperature (Tocher and Sargent 1990 ) and xenobiotics (Ghioni et al. 1998) . Alterations in the relative proportions of PC and PE are also common in adaptation of fish to environmental factors such as temperature, salinity and hydrostatic pressure (Tocher 1995) but no such alteration was observed in response to EFA deficiency in the present study.
In comparison with salmonid cell lines, EPC cells were similar to Atlantic salmon (AS) cells in which 20:4n-3 was the predominant product of 18:3n-3 desaturation rather than 20:5n-3, as in rainbow trout (RTG-2) cells (Tocher and Sargent 1990; Ghioni et al. 1998) . However, EPC cells and, especially, EPC-EFAD cells produced far more 22:6n-3, both from [1-14 C]18:3n-3 and [1-14 C]20:5n-3, than the other freshwater cell lines investigated previously (Tocher and Sargent 1990; Ghioni et al. 1998) . It was noteworthy that the effect of essential fatty acid deficiency on the desaturation and elongation of [1-14 C]18:3n-3 and [1-14 C]18:2n-6 was different. The production of 5 products of [1-14 C]18:3n-3 was doubled in EPC-EFAD cells and the radioactivity recovered in 22:6n-3 was over 4-fold higher whereas there was apparently less effect on 6 desaturase and C 18−20 elongase. With [1-14 C]18:2n-6, 5 products were also increased by about 10-fold in EPC-EFAD cells but 6 desaturase products were also doubled. The precise reason for the apparent difference in the pathway using the different C 18 PUFA substrates is not known but it is important to appreciate that the data for C 18−20 elongase and all subsequent enzymes are, of course, not independent of preceding activities and labeled versions of the direct substrates of each activity are required to further investigate this apparent effect. Previously, it was shown that both 6 and 5 desaturases in human Hep G2 cells incubated with 14 C-labeled 18:2n-6 were apparently rate-limiting and upregulated in EFA deficiency (Melin and Nilsson 1997) .
In conclusion, the present study has demonstrated that the carp cell line, EPC, has a complete fatty acid desaturation and elongation pathway, and can biosynthesize 22:6n-3 from 18:3n-3 and 20:4n-6 from 18:2n-6. The overall desaturation of PUFA was increased by essential fatty acid deficiency with apparently increased desaturase activities, rather than increased elongase activities, in EPC-EFAD cells. Therefore, the previously reported inability of 18:3n-3 and 18:2n-6, in comparison to C 20 and C 22 PUFA, to stimulate proliferation of EPC-EFAD cells was not due to a general deficiency in the desaturase pathway. However, it may be related to accumulation of 20:4n-3 and 20:3n-6, with their associated potential to alter eicosanoid profiles, in cells supplemented with C 18 PUFA although this requires further investigation.
